Edit Entry | Edit CV

Florian R Schroeck, MD, MS

Title(s)
Associate Professor of Surgery
Associate Professor of The Dartmouth Institute

Additional Titles/Positions/Affiliations
Section Chief of Urology, White River Jct. VA Medical Center

Department(s)
Surgery
The Dartmouth Institute

Websites
https://tdi.dartmouth.edu/about/our-people/directory/florian-schroeck-md-ms

Contact Information


Selected Publications

 

Feasibility and outcomes of interventions to reduce cystoscopy discomfort: a multi-site pilot study.
Desai AP, Basak RS, Lotan Y, Sperger J, Schroeck FR, Lipman R, Chaplin I, Roberson H, Lopez P, Jenkins W, Gore JL, Kosorok MR, Smith AB
BJU Int. 2025 May 24; doi: 10.1111/bju.16794. Epub 2025 May 24.
PMID: 40411348

Integration and evaluation of implementation strategies to improve guideline-concordant bladder cancer surveillance: a prospective observational study.
Zubkoff L, Ould Ismail AA, Jensen L, Haggstrom DA, Kale S, Issa MM, Tosoian JJ, Siddiqui MM, Bloomquist K, Kimball ER, Zickmund S, Schroeck FR
Implement Sci Commun. 2025 Apr 7;6(1):37. doi: 10.1186/s43058-025-00721-0. Epub 2025 Apr 7.
PMID: 40197353

The Management of Non-Muscle-Invasive Bladder Cancer in a Veteran Patient Population: Issues and Recommendations.
Taylor J, Patel S, Gaitonde K, Greene K, Liao JC, McWilliams G, Sawyer M, Schroeck F, Alrabaa A, Saffati G, Kronstedt S, Jones J
Curr Oncol. 2024 Oct 28;31(11):6686-6698. doi: 10.3390/curroncol31110493. Epub 2024 Oct 28.
PMID: 39590124

Adherence to Synoptic Cancer Pathology Reporting Among Pathologists in the National Department of Veterans Affairs Health Care System.
Ould Ismail AA, Kale S, McGonagle K, Hill B, Pettus JR, DuVall SL, Ferraro JP, Schroeck FR
Arch Pathol Lab Med. 2024 Nov 8; doi: 10.5858/arpa.2024-0229-OA. Epub 2024 Nov 8.
PMID: 39514644

Non-Muscle Invasive Bladder Cancer: Many More Patients Die With It Than Of It.
McGonagle K, Dematt EJ, Mi Z, Biswas K, Schroeck FR
Bladder Cancer. 2024;10(2):113-117. doi: 10.3233/BLC-230099. Epub 2024 Jun 18.
PMID: 39131873

Editorial Comment on "Teaching Hospitals and Textbook Outcomes After Major Urologic Cancer Surgery".
Schroeck FR
Urology. 2024 Sep;191:71. doi: 10.1016/j.urology.2024.06.066. Epub 2024 Jul 4.
PMID: 38971233

Clinical Trial Protocol for "Replace Cysto": Replacing Invasive Cystoscopy with Urine Testing for Non-muscle-invasive Bladder Cancer Surveillance-A Multicenter, Randomized, Phase 2 Healthcare Delivery Trial Comparing Quality of Life During Cancer Surveillance with Xpert Bladder Cancer Monitor or Bladder EpiCheck Urine Testing Versus Frequent Cystoscopy.
Schroeck FR, Grubb R, MacKenzie TA, Ould Ismail AA, Jensen L, Tsongalis GJ, Lotan Y
Eur Urol Open Sci. 2024 May;63:19-30. doi: 10.1016/j.euros.2024.02.018. Epub 2024 Mar 21.
PMID: 38558761

Accurate Documentation Contributes to Guideline-concordant Surveillance of Nonmuscle Invasive Bladder Cancer: A Multisite Department of Veterans Affairs Study.
Lyall V, Ould Ismail AA, Haggstrom DA, Issa MM, Siddiqui MM, Tosoian J, Schroeck FR
Urology. 2023 Nov;181:92-97. doi: 10.1016/j.urology.2023.08.014. Epub 2023 Sep 1.
PMID: 37660946

Urinary Analysis of FGFR3 and TERT Gene Mutations Enhances Performance of Cxbladder Tests and Improves Patient Risk Stratification.
Lotan Y, Raman JD, Konety B, Daneshmand S, Schroeck F, Shariat SF, Black P, de Lange M, Asroff S, Goldfischer E, Efros M, Chong KT, Huang E, Chua HL, Wu QH, Yeow S, Lau W, Yong J, Eng M
J Urol. 2023 Apr;209(4):762-772. doi: 10.1097/JU.0000000000003126. Epub 2022 Dec 30.
PMID: 36583640

Data-driven approach to implementation mapping for the selection of implementation strategies: a case example for risk-aligned bladder cancer surveillance.
Schroeck FR, Ould Ismail AA, Haggstrom DA, Sanchez SL, Walker DR, Zubkoff L
Implement Sci. 2022 Sep 1;17(1):58. doi: 10.1186/s13012-022-01231-6. Epub 2022 Sep 1.
PMID: 36050742

View more publications on PubMed